Toll‐like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients
- 3 May 2010
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 31 (11) , 1192-1199
Abstract
Aliment Pharmacol Ther 31, 1192–1199 Background Toll-like receptor (TLR) 4 genetic polymorphisms, mainly D299G, have been associated with increased predisposition to infection in several populations. Aim To retrospectively analyse the relationship between the presence of the TLR4 D299G polymorphism and the incidence of bacterial infections in cirrhotic patients. Methods We included 111 consecutive cirrhotic patients hospitalized with ascites and we determined the presence of the TLR4 D299G polymorphism by PCR–RFLP (polymerase chain reaction–restriction fragment length polymorphism) and its relationship with the incidence of previous bacterial infections. Results Ten out of 111 (9%) cirrhotic patients presented with the TLR4 D299G polymorphism. The mean follow-up from first decompensation of cirrhosis until current admission was longer in D299G polymorphism patients than in wild-type patients (53.8 ± 40.7 vs. 35.4 ± 48.3 months, P = 0.03). D299G polymorphism patients showed a trend towards a higher incidence of history of previous infections (80% vs. 56.4%, P = 0.19), as well as a higher number of infections (2.8 ± 2.3 vs. 1.0 ± 1.3, P = 0.01) and bacteriaemias (0.4 ± 1.0 vs. 0.04 ± 0.2, P = 0.02) per patient than wild-type patients. Conclusions Toll-like receptor 4 D299G polymorphism could influence not only the predisposition to bacterial infections but also the evolution of the disease in cirrhotic patients. Further prospective studies in larger series of patients are warranted.Keywords
This publication has 42 references indexed in Scilit:
- Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infectionJournal of Hepatology, 2009
- A Seven-Gene Signature (Cirrhosis Risk Score) Predicts Liver Fibrosis Progression in Patients with Initially Mild Chronic Hepatitis C†Hepatology, 2009
- Ascites improves upon plus serum sodium model for end‐stage liver disease (MELD) for predicting mortality in patients with advanced liver diseaseAlimentary Pharmacology & Therapeutics, 2009
- Toll-like receptors as targets in chronic liver diseasesGut, 2009
- Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses†‡Hepatology, 2009
- Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell TransplantationNew England Journal of Medicine, 2008
- TLRPolymorphisms and the Risk of Invasive Fungal InfectionsNew England Journal of Medicine, 2008
- Study of Toll-like receptor gene loci in sarcoidosisClinical and Experimental Immunology, 2008
- Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitisHepatology, 2008
- MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infectionJournal of Experimental Medicine, 2007